Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Inventor Singh Rohit
Introduction
Singh Rohit is a notable inventor based in Chuncheon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer treatment. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Singh Rohit holds a patent for an "Antibody binding specifically to human and mouse L1CAM protein, and use therefor." This invention relates to a novel antibody that specifically binds to both human and mouse L1CAM with high affinity. The patent details the preparation of this antibody, which involves modifying a sequence of an L1 cell adhesion molecule (L1CAM)-specific antibody. The invention also encompasses a polynucleotide encoding the antibody, an expression vector, a transformant introduced with the vector, and various pharmaceutical compositions for preventing or treating cancer. Additionally, it includes methods for diagnosing cancer and an antibody-drug conjugate prepared by conjugating a drug to the antibody.
Career Highlights
Throughout his career, Singh Rohit has worked with esteemed institutions such as Kangwon National University University-Industry Cooperation Foundation and the Korea Research Institute of Bioscience and Biotechnology. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Singh Rohit has collaborated with notable coworkers, including Hyo Jeong Hong and In Soo Park. These partnerships have further enriched his research and development efforts, leading to advancements in cancer treatment methodologies.
Conclusion
Singh Rohit's innovative work in antibody development exemplifies his commitment to improving cancer treatment options. His contributions to biotechnology are significant and continue to impact the field positively.